| COMPOSITION: | Each film coated bilayered tablet contains Dapaglifozin 10 mg , Glimepride 2mg and Metformin (ER) 500 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Dapaford-GM 2 tablets contains Dapagliflozin, Metformin and Glimepiride. The combination of these three medications helps in managing type 2 diabetes effectively. Dapagliflozin helps lower blood sugar by promoting glucose excretion via urine, Metformin improves insulin sensitivity and reduces glucose production in the liver & Glimepiride stimulates insulin release from the pancreas to further regulate blood sugar levels. Together, these medications provide comprehensive control over glucose levels in patients with type 2 diabetes, helping to maintain stable blood sugar levels and reduce the risk of complications associated with diabetes. |
| SIDE EFFECTS: | May include hypoglycemia (especially due to Glimepiride), urinary tract infections, genital mycotic infections, gastrointestinal disturbances, and rarely lactic acidosis with Metformin. Always monitor renal function and blood glucose levels regularly. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
